Joong-Won Park

16.0k total citations
8 papers, 301 citations indexed

About

Joong-Won Park is a scholar working on Hepatology, Epidemiology and Cancer Research. According to data from OpenAlex, Joong-Won Park has authored 8 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 3 papers in Epidemiology and 3 papers in Cancer Research. Recurrent topics in Joong-Won Park's work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Joong-Won Park is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Liver Disease Diagnosis and Treatment (3 papers) and Cancer, Lipids, and Metabolism (2 papers). Joong-Won Park collaborates with scholars based in South Korea, United States and Japan. Joong-Won Park's co-authors include Chang‐Min Kim, Kyung Woo Park, Keon Wook Kang, Seok Ki Kim, Ji Hoon Kim, Woo Jin Lee, Byung Ho Nam, Bo Hyun Kim, Yeon-Joo Kim and Sung Hoon Kim and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Nuclear Medicine and Frontiers in Medicine.

In The Last Decade

Joong-Won Park

7 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joong-Won Park South Korea 6 190 98 94 92 65 8 301
Satoshi Sasayama Japan 6 120 0.6× 149 1.5× 40 0.4× 82 0.9× 78 1.2× 16 342
Denise N. Gansen United States 7 138 0.7× 49 0.5× 72 0.8× 28 0.3× 67 1.0× 8 272
Jen-Fu Yang Taiwan 11 155 0.8× 60 0.6× 54 0.6× 46 0.5× 74 1.1× 20 277
Sonia Sahu United States 13 149 0.8× 133 1.4× 82 0.9× 24 0.3× 101 1.6× 16 318
Woo Jin Lee South Korea 6 292 1.5× 141 1.4× 119 1.3× 99 1.1× 114 1.8× 8 455
D Bekhechi France 5 323 1.7× 144 1.5× 137 1.5× 77 0.8× 51 0.8× 6 444
P Hilgard Germany 5 220 1.2× 47 0.5× 62 0.7× 32 0.3× 72 1.1× 6 309
Feng Ji-liang China 8 147 0.8× 82 0.8× 56 0.6× 58 0.6× 57 0.9× 17 245
Ermanno Notarianni Italy 6 153 0.8× 63 0.6× 32 0.3× 21 0.2× 86 1.3× 16 250
S.M. Ibrahim United States 5 401 2.1× 42 0.4× 193 2.1× 44 0.5× 51 0.8× 12 459

Countries citing papers authored by Joong-Won Park

Since Specialization
Citations

This map shows the geographic impact of Joong-Won Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joong-Won Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joong-Won Park more than expected).

Fields of papers citing papers by Joong-Won Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joong-Won Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joong-Won Park. The network helps show where Joong-Won Park may publish in the future.

Co-authorship network of co-authors of Joong-Won Park

This figure shows the co-authorship network connecting the top 25 collaborators of Joong-Won Park. A scholar is included among the top collaborators of Joong-Won Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joong-Won Park. Joong-Won Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lee, Dong Ho, Young Hwan Koh, Kyung-Hun Lee, et al.. (2021). Outcome of Initial Progression During Nivolumab Treatment for Hepatocellular Carcinoma: Should We Use iRECIST?. Frontiers in Medicine. 8. 771887–771887. 9 indexed citations
2.
Ahn, Keun Soo, Daniel R. O’Brien, Yong‐Hoon Kim, et al.. (2021). Associations of Serum Tumor Biomarkers with Integrated Genomic and Clinical Characteristics of Hepatocellular Carcinoma. Liver Cancer. 10(6). 593–605. 21 indexed citations
3.
Kudo, Masatoshi, Richard S. Finn, Shukui Qin, et al.. (2020). Overall Survival and Objective Response in Advanced Unresectable Hepatocellular Carcinoma: A Subanalysis of the REFLECT Study. SSRN Electronic Journal. 3 indexed citations
4.
Park, Joong-Won, et al.. (2017). Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area. Therapeutic Advances in Gastroenterology. 10(7). 529–536. 23 indexed citations
5.
Kim, Tae Hyun, Joong-Won Park, Yeon-Joo Kim, et al.. (2014). Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma. Strahlentherapie und Onkologie. 190(10). 882–890. 29 indexed citations
6.
Park, Joong-Won, Morris Sherman, Massimo Colombo, et al.. (2012). Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC bridge study: First characterization of the full study population.. Journal of Clinical Oncology. 30(15_suppl). 4033–4033. 17 indexed citations
7.
Park, Joong-Won, Ji Hoon Kim, Seok Ki Kim, et al.. (2008). A Prospective Evaluation of18F-FDG and11C-Acetate PET/CT for Detection of Primary and Metastatic Hepatocellular Carcinoma. Journal of Nuclear Medicine. 49(12). 1912–1921. 197 indexed citations
8.
Park, Joong-Won. (2008). New Targeted Agents for Hepatocellular Carcinoma. 8(1). 16–17. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026